Journal article Synergistic effects of metal-organic nanoplatform and guanine quadruplex-based CpG oligodeoxynuceotides in therapeutic cancer vaccines with different tumor antigens
Xia Li (author) (Search by this author)
ORCID https://orcid.org/0000-0002-3246-4462
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Smart Polymers Group, National Institute for Materials Science
SAMURAI NIMS Researchers Directory SAMURAI
ORCID SAMURAI ;
Mitsuhiro Ebara (author) (Search by this author)
ORCID https://orcid.org/0000-0002-7906-0350
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Smart Polymers Group, National Institute for Materials Science
SAMURAI NIMS Researchers Directory SAMURAI
ORCID SAMURAI ;
Naoto Shirahata (author) (Search by this author)
ORCID https://orcid.org/0000-0002-1217-7589
Research Center for Materials Nanoarchitectonics (MANA)/Nanomaterials Field/Nanoparticle Group, National Institute for Materials Science
SAMURAI NIMS Researchers Directory SAMURAI
ORCID SAMURAI ;
Tomohiko Yamazaki (author) (Search by this author)
ORCID https://orcid.org/0000-0003-2136-8042
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Medical Soft Matter Group, National Institute for Materials Science
SAMURAI NIMS Researchers Directory SAMURAI
ORCID SAMURAI ;
Nobutaka Hanagata (author) (Search by this author)
ORCID https://orcid.org/0000-0001-6079-3426
National Institute for Materials Science
SAMURAI NIMS Researchers Directory SAMURAI
ORCID SAMURAI
2024 Vaccines -Xia Li.pdf
Download file (5.12 MB)
Download as zip (4.55 MB)
Collection

Citation
Xia Li, Mitsuhiro Ebara, Naoto Shirahata, Tomohiko Yamazaki, Nobutaka Hanagata. Synergistic effects of metal-organic nanoplatform and guanine quadruplex-based CpG oligodeoxynuceotides in therapeutic cancer vaccines with different tumor antigens. Vaccines. 2024, 12 (6), 649. https://doi.org/10.3390/vaccines12060649
SAMURAI

Description:

(abstract)

Oligodeoxynucleotides (ODNs) containing unmethylated cytosine-phosphate-guanosine (CpG) motifs are readily recognized by Toll-like receptor 9 on immune cells, trigger an immunomodulatory cascade, induce a Th1 -biased immune milieu and have a great potential as an adjuvant in cancer vaccines. In this study, a green one-step synthesis process was adopted to prepare amino-rich metal-organic nanoplatform (FN). The synthesized FN nanoplatform can simultaneously and ef-fectively load model tumor antigens (OVA) / autologous tumor antigens (dLLC) and im-munostimulatory CpG ODNs with an unmodified PD backbone and guanine-quadruplex structure to obtain various cancer vaccines. The FN nanoplatform and immunostimulatory CpG ODNs generate synergistic effects to enhance the immunogenicity of different antigens and inhibit the growth of established and distant tumors in both the murine E.G7-OVA lymphoma model and the murine Lewis lung carcinoma model. In E.G7-OVA lymphoma model, vaccination efficiently in-crease the CD4+, CD8+ and tetramer+CD8+ T cell populations in the spleens. In Lewis lung carci-noma model, vaccination efficiently increase the CD3+CD4+ and CD3+CD8+ T cell populations in the spleens and CD3+CD8+, CD3-CD8+ and CD11b+CD80+ cell populations in the tumors, suggesting the alteration of tumor microenvironment from cold to hot tumors.

Rights:

Keyword: TLR9 agonist, CpG oligodeoxynucleotides, nanoplatform, cancer vaccines, adjuvant

Date published: 2024-06-11

Publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Journal:

  • Vaccines (ISSN: 2076393X) vol. 12 issue. 6 649

Funding:

  • KAKENHI 23K04555 and 22K20517
  • Takeda Science Foundation

Manuscript type: Publisher's version (Version of record)

MDR DOI:

First published URL: https://doi.org/10.3390/vaccines12060649

Related item:

Other identifier(s):

Contact agent:

Updated at: 2024-06-28 08:30:16 +0900

Published on MDR: 2024-06-28 08:30:16 +0900

Filename Size
Filename 2024 Vaccines -Xia Li.pdf (Thumbnail)
application/pdf 		Size 5.12 MB Detail